A Four-Channel Microfluidic Vascular-Wall Chip for Modeling Early Atherosclerosis-Related Endothelial Dysfunction and Evaluating Combined Anti-Inflammatory Treatment
Micromachines · 18.06.2026 · 17 (6) · 734
DOI: 10.3390/mi17060734 ↗Kurz gefasst
Fachartikel in der Zeitschrift Micromachines, online erschienen am 18.06.2026. Verfasst von Xulong Wu und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Microelectronics, Shanghai University, Shanghai 200444, China. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chinese Academy of Sciences, National Key Research and Development Program of China, CAS-NSTDA.
Abstract (Originalsprache)
Atherosclerosis begins with endothelial dysfunction, inflammatory activation, and immune-cell recruitment within a spatially organized vascular wall. Conventional static cultures and Transwell systems are advantageous for isolated readouts, but they fail to effectively recapitulate multicellular compartmentalization, extracellular matrix support, and dynamic perfusion within a singular platform. Here, we present a four-channel microfluidic vascular-wall chip designed to reconstitute an endothelial cell-extracellular matrix-smooth muscle cell arrangement and to model early atherosclerosis-related inflammatory endothelial dysfunction. The device comprises a perfusable endothelial channel, a collagen I hydrogel region embedded with human aortic smooth muscle cells, a cell-free matrix region, and a culture-medium supply channel. Under physiological conditions, HUVECs formed a ZO-1-positive endothelial barrier and maintained high cellular viability. Stimulation with TNF-α and IL-1β (10 ng/mL each) elevated IL-6 secretion, promoted the recruitment of THP-1-derived M0-like macrophages, disrupted ZO-1 continuity, and increased FITC-dextran permeability without causing extensive cell death. The chip was subsequently utilized to evaluate metformin and atorvastatin therapies. The combinational treatment produced a more pronounced attenuation of MCP-1 secretion than either monotherapy under the inflammatory background. While this platform does not recapitulate advanced plaque formation, lipid deposition, foam-cell formation, or disturbed arterial shear, it successfully provides a microfluidic model of early inflammatory endothelial dysfunction to facilitate mechanistic studies and preliminary anti-inflammatory drug evaluation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Microelectronics, Shanghai University, Shanghai 200444, China.
- Shanghai Institute of Microsystems and Information Technology, Chinese Academy of Sciences, Shanghai 200050, China.
- School of Physics and Optoelectronic Engineering, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou 310024, China.
- Human Phenome Institute, Fudan University, Shanghai 200438, China.
Förderung
- Chinese Academy of Sciences
- National Key Research and Development Program of China
- CAS-NSTDA
Zitieren
APA
Wu, X., Xu, Y., Zhao, X., & Mi, X. (2026). A Four-Channel Microfluidic Vascular-Wall Chip for Modeling Early Atherosclerosis-Related Endothelial Dysfunction and Evaluating Combined Anti-Inflammatory Treatment. Micromachines, 17(6), 734. https://doi.org/10.3390/mi17060734
Vancouver
Wu X, Xu Y, Zhao X, Mi X. A Four-Channel Microfluidic Vascular-Wall Chip for Modeling Early Atherosclerosis-Related Endothelial Dysfunction and Evaluating Combined Anti-Inflammatory Treatment. Micromachines. 2026;17(6):734. doi:10.3390/mi17060734
BibTeX
@article{Wu2026,
author = {Wu, Xulong and Xu, Yi and Zhao, Xiaoshuang and Mi, Xianqiang},
title = {A Four-Channel Microfluidic Vascular-Wall Chip for Modeling Early Atherosclerosis-Related Endothelial Dysfunction and Evaluating Combined Anti-Inflammatory Treatment},
journal = {Micromachines},
year = {2026},
volume = {17},
number = {6},
pages = {734},
doi = {10.3390/mi17060734}
}
EUVIMED